Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Research and Development Expenses (Tables)

v3.10.0.1
Research and Development Expenses (Tables)
12 Months Ended
Dec. 31, 2017
Research And Development Expenses  
Schedule of research and development expenses
   

Year ended

December 31,

 
      2017     2016     2015  
      USD  
                     
  Clinical and preclinical trials   $ 3,809     $ 5,104     $ 2,814  
  Salary and related expenses     888       664       663  
  Patents     234       198       216  
  Royalties     11       11       61  
  Laboratory materials     63       38       49  
  Rent     51       48       47  
  Depreciation     3       4       4  
  Others     47       48       50  
                           
      $ 5,106     $ 6,115     $ 3,904